axitinib,sunitinib,pembrolizumab
pfizer,merck
['inlyta', 'key,note,42', 'keytruda', 'pembro', 'rcc,(-irccs),(-srcc),(-urcc)', 'keynote 426', 'key,note,426']
incredible info on the #keynote 426 follow up from comparing pembro/axi vs sutinib in advanced ccrcc . #keytruda #inlyta #asco23 #kidneycancer #kidneycancerclinicaltrials #patientadvocate 
Metastatic kidney cancer survivor. HLRCC patient. Statistical abnormality. Fighting for cures. Cajun in exile in Cali. Views=mine/RTs ≠ endorsements. she/her